SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias board investigation into CEO Jensen Huangs relationship with a businesswoman alleged to have ties to Chinese intelligence has raised governance, disclosure and leadership concerns. Traders are divided between treating the controversy as a temporary distraction and buying on the strength of Nvidias AI business, and worrying that further scrutiny could threaten Huangs position.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desks sharp rally followed a Q3 revenue and adjusted-EPS beat, with Q4 guidance also coming in above expectations. The results fueled relief and short-squeeze chatter, though some traders remain skeptical that one strong report proves a sustained turnaround after the stocks prolonged decline.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

A steep, high-volume selloff ahead of Hims & Hers Q3 earnings has sparked speculation among traders about a possible information leak, though there is no confirmation. The debate centers on whether results and guidance can offset concerns that the Lilly branded obesity-drug partnership may pressure margins; some see expanded access as a growth opportunity, while others focus on profitability.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists upcoming third-quarter results and conference call are driving attention, with traders looking for earnings guidance and updates on SK hynix, product sales, and a possible Nasdaq relisting. Optimism about the report is tempered by high expectations and recent weakness across memory and AI stocks; discussion also flags the companys Kingston-related patent actions as a potential catalyst.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics Q3 revenue beat and higher full-year outlook, driven by BRIUMVI sales growth, are the main focus. Traders debated the sharp post-earnings dip and recovery, with many treating the pullback as an opportunity; upcoming subcutaneous BRIUMVI Phase 3 data is another focus, while buyout and short-squeeze claims remain speculative.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two is drawing attention ahead of its earnings report and the scheduled GTA VI launch, with traders focused on preorder demand and managements outlook. Bulls see the game and future online spending as major growth drivers, while skeptics argue expectations may already be priced in and worry about a sell-the-news reaction amid the stocks weakness.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

ASTS is drawing attention after the Rakuten Japan satellite-network joint venture secured government backing, alongside anticipation for its earnings and business update following the Firefly Blacklift rocket plan. Bulls see new commercial opportunity and greater control over launches; skeptics question the timeline, execution, cash burn, and potential dilution.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXOs preliminary third-quarter results and Brad Jacobs upbeat discussion of the business outlook have fueled a sharp rally. Many traders are cheering the update and speculating that short covering could add momentum, while some are cautious about a post-earnings pullback.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X ETF

A sharp, volatile semiconductor selloff amid concerns about AI and data-center spending has drawn traders to SOXS as a leveraged inverse play. The community is split between expecting more chip weakness and anticipating a rebound, with many emphasizing the funds daily leverage, rapid swings, and decay risk.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors HOPE-3 cardiac results for deramiocel received an American Heart Association research award, renewing attention ahead of the FDAs pending decision on the therapy for Duchenne muscular dystrophy. Traders see the recognition and physician support as strengthening the case for approval, while others note that an award does not determine the FDA outcome and the cardiac evidence faced a negative advisory-panel vote.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
